The psychopharmacologization of childhood and the Disease centered model of drug action
DOI:
https://doi.org/10.5007/2175-7984.2020.e74538Abstract
The prescription and wide acceptance of the use of classic and atypical antipsychotics in childhood and adolescence was legitimated by relying on the supposed therapeutic and curative functions of these drugs. Taking as a starting point the distinction of two explanatory models of action of psychoactive drugs, one centered on the disease and the other centered on the drug, I analyze how the pharmaceutical industry has contributed, with its marketing strategies, to the dissemination of a triumphalist narrative that naturalized the use of antipsychotics as a cure
for psychiatric diseases. The two psychopharmaceuticals analyzed are chlorpromazine, a classic antipsychotic, and risperidone, an atypical, state-of-the-art antipsychotic.
References
ABRASME NOTICIA. Mais de mil meninos tiveram seus seios crescidos, causa provável a risperidona 02/02/2015. ABRASME p. 1–2 , 2015.
ANVISA. Bula Amplictil . [S.l.]: Anvisa. Disponível em: <http://www.saudedireta.com.br/catinc/drugs/bulas/amplictil.pdf>. , 2018
ANVISA. Quadro 1 . Resumo de indicações de antipsicóticos e uso na faixa etária pediátrica de acordo com as respectivas bulas brasileiras . [S.l: s.n.], 2014.
APA. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington. Arlington: American Psychiatric Association, 2013. .
BBC, News. Risperdal , el fármaco por el que Johnson & Johnson deberá pagar US $ 8 . 000 millones a un joven a quien le crecieron los pechos Efectos colaterales adversos. 9 out. 2019 Disponível em: <https://www.bbc.com/mundo/noticias-49987187>.
BREGGIN, P. Medication Madness. New York: St. Martin’s Press, 2008. .
BREGGIN, P. Toxic Psychiatry. New York: St. Martin’s Press, 1991.
BREGGIN, P. Rational Principles of Psychopharmacology for Therapists, Healthcare Providers and Clients. Journal of Contemporary Psychotherapy v. 46, n. 1, p. 1–13 , 2016.
CAPONI, S. Uma sala tranquila: antipsicóticos para uma biopolitica da indiferença. São Paulo: LiberArs, 2019. .
DELAY, J; DENIKER, P; BOURGUIGNON, A. Extrapyramidal movement disorders during chlorpromazine and reserpine therapy. Encephale v. 45, n. 4, p. 1093–8 , 1956.
DELAY, J; DENIKER, P. Utilisation en Therapeutique psychiatrique d´une phenithiazine d´action centrale élective (4560 RP). Annales médico-psychologiques v. 110, n. 2, p. 112–131 , 1952.
DENIKER, P. Psychopharmacologie. Les médicaments et drogues psychotropes. Paris: Ellipses, 1987.
FREITAS, F; AMARANTE, P. Medicalização em psiquiatria. Rio de janeiro: FIOCRUZ, 2015.
GALARCE, M. Uso de risperidona em niños. Pontificia Univ. Chlie, 2008. 1–8 p. Disponível em: <https://medicina.uc.cl/publicacion/uso-de-risperidona-en-ninos-efectividad-y-perfil-de-seguridad/>.
GOTSZCHE, P. Psicofármacos que matam y denegación organizada. Barcelona: Los libros del lince, 2016. .
INSEL, T. Rethinking schizophrenia. Nature v. 468, n. 7321, p. 187–193 , 2010.1476-4687 (Electronic)n0028-0836 (Linking).
JANSSEN. RISPERIDAL Products L.P. . [S.l.]: Janssen. , 2003
JOHNSON & JOHNSON. A n n u a l R e p o r t 2 017. , 2017. Disponível em: <https://www.jnj.com/2017-year-in-review>.
KRISTOF, N.. When Crime Pays : J & J ’ s Drug Risperdal. New York Times n. September 17th, p. 1–3 , 2015.
LANE, Ch.. Antipsychotics Tied to Higher Risk of Death in Children. Disponível em: <https://www.psychologytoday.com/intl/blog/side-effects/201812/antipsychotics-tied-higher-risk-death-in-children>.
MAGALHÃES BRAGA, A.. Uso De Psicofármacos Na Infância E Na Adolescência Para O Pediatra Geral. Brasília Médica v. 48, n. 3, p. 299–307 , 2011.
MONCRIEFF, J.; COHEN, D. Rethinking models of psychotropic drug action. Psychotherapy and Psychosomatics v. 74, n. 3, p. 145–153 , 2005.0033-3190 (Print)n0033-3190 (Linking).
MONCRIEFF, J. Hablando claro: una introducción a los fármacos psiquiatricos. Barcelona: Herder, 2013a.
MONCRIEFF, J. Las incómodas verdades acerca de los antipsicóticos : Una respuesta a Goff et al . Mad in América , 2017. Disponível em: <http://madinamerica-hispanohablante.org/las-incomodas-verdades-acerca-de-los-antipsicoticos-una-respuesta-a-goff-et-al-joanna-moncrieff/>.
MONCRIEFF, J. Magic bullets for mental disorders: The emergence of the concept of an “Antipsychotic” drug. Journal of the History of the Neurosciences v. 22, n. 1, p. 30–46 , 2013b.
MONCRIEFF, J. Models of drug action. n. 4, p. 6–11 , 2013c. Disponível em: <https://joannamoncrieff.com/2013/11/21/models-of-drug-ation/>.
MONCRIEFF, J. The Myth of the Chemical Cure. London: Palgrave MacMillan, 2008.
MONCRIEFF, J.; MIDDLETON, H. Schizophrenia: A critical psychiatry perspective. Current Opinion in Psychiatry v. 28, n. 3, p. 264–268 , 2015.
NYT. "Serenity" Drugs disturb doctors ; Side Effects in Treatment of Mentally Ill Are Cited at Manufacturers ’ Meeting. The New York Times p. 3 , 1955.
NYT. NEW DRUG HAILED AS TRANQUILIZER ; 550 Patients Are Calmed by Promazine--No Side Reactions Noted in Test. The New York Times p. 25 , 1956.
NYT. Ups and Downs With Pills. The New York Times v. 23/6, p. 1957 , 1957.
PIGNARRE, P. Les malheurs des psys: psychotropes et médicalisation du social. Paris: La Découverte, 2006. .
PLUMB, R. Drug Use. New York Times p. 1 , 1955a.
PLUMB, R. Drug use hailed in mental cases; State Hospitals Report Big Therapeutic Gains With the New Compounds. The New York Times , 1955b.
PLUMB, R. Tranquil wards show drugs’ help. The New York Times p. 1956 , 1956.
PROCON.ORG. Prescription Drugs Advertising.
RODRIGUES, A. Ministério da Saúde estuda distribuir risperidona a usuários de crack e cocaína. Agencia Brasil p. 1–5 , 2014.
SECRETARIA DE SAÚDE SÃO JOSÉ DE RIO PRETO(SP). Protocolo de tratamento de transtornos desafiador opositor e transtorno de conduta - risperidona., 2018. Disponível em: http://saude.riopreto.sp.gov.br/transparencia/arqu/arqufunc/2018/risperidona_tod.pdf>.
TCHEREMISSINE, O.; LIEVING, L. Pharmacological Aspects of the Treatment of Conduct Disorder in Children and Adolescents. Terapy in Practice v. 20, n. 7, p. 549–565 , 2006.
VIZOTTO, L.; FERRAZZA, D. Childhood in the hotseat: On diagnostic labeling and the trivialized practice of psychotropic prescriptions. Estudos de Psicologia v. 22, n. 2, p. 214–224 , 2017.
WHITAKER, R.. Anatomia de uma epidemia. Medicamentos psiquiátricos y el asombroso aumento de las enfermedades mentales. Madrid: Ed. Capitan Swing, 2015. .
WHITAKER, R.. La psiquiatría defiende sus antipsicóticos : Un caso práctico de corrupción institucional // Robert Informe MIA : La psiquiatría defiende sus antipsicóticos . Un caso práctico de corrupción institucional. p. 6–8 , 2017.
WHITAKER, R. Mad in America. Bad Science, bad medecine,and the enduring mistratment of the mentallu ill. New York: Basic Books. A membrer of Perseus Books Group, 2010.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Política & Sociedade
This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles and other work published in Política & Sociedade, a journal associated to the Graduate Program in Sociology at UFSC, are the property of the journal. A new publication of the same text, whether by the initiative of the author or third parties, must indicate that it was previously published in this journal, citing the edition and date of publication.
This work is licensed under the Creative Common License
